| jeudi 9 juillet 2009 |
07:30 - 08:30: Registration, Coffee
|
08:30 - 09:00: Welcome address
|
| Salles: |
AMPHITHEATRE BLEU |
| 08:30 |
Welcome adress
THOMAS TURSZ (VILLEJUIF, FR) |
09:00 - 10:40: STRATEGIC VISION ON PERSONALIZED MEDICINE
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
MARCO PIEROTTI (MILAN, IT), YE DING-WEI (SHANGHAI, CN) |
| 09:00 |
Opening Keynote Lecture: The concept of personalized cancer medicine
RICHARD L. SCHILSKY (CHICAGO, US) |
| 09:25 |
The challenges of Personalized medicine and modern oncology: towards early diagnosis and individual tailored treatment in cancer patients
THOMAS TURSZ (VILLEJUIF, FR) |
| 09:50 |
Systems Biology to decipher complexity of cancer disease
LEROY HOOD (SEATTLE, US) |
| 10:15 |
Personalized medicine in the treatment of solid tumors: from concepts to reality
IGNACIO IVAN WISTUBA (HOUSTON, US) |
10:40 - 11:00: Coffee Break and networking Discussions
|
11:00 - 12:40: ADVANCED SCIENTIFIC CONCEPTS IN PERSONALIZED MEDICINE
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
LEROY HOOD (SEATTLE, US), MANFRED SCHMITT (M?NCHEN, DE) |
| 11:00 |
The need for Diseases Models with "Commons" as a mean to share data
STEPHEN FRIEND (PENNSYLVANIA, US) |
| 11:25 |
Using genomic information to personalize diagnosis and treatment of cancer
RENE BERNARDS (AMSTERDAM, NL) |
| 11:50 |
Modeling human cancer in mice
MARIANO BARBACID (MADRID, ES) |
| 12:15 |
Advanced measurement and integrated data analysis: the gateway to the future of predictive medicine
ZOHAR YACHINI (HAIFA, IL) |
12:40 - 14:00: Lunch and networking Discussions
|
14:00 - 16:05: ADVANCED TECHNOLOGY DEVELOPMENTS (1)
This session celebrates the 10th Anniversary of Agilent Life Sciences Technologies |
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
DANILO CAZZOLA (SANTA CLARA, US), ROBERT SIGAL (*, FR) |
| 14:00 |
Practical application of multiple high-throughput technologies in cancer diagnostics and therapy selection.
OLLI KALLIONIEMI (HELSINKI, FI) |
| 14:25 |
Current and future challenges in bioanalytical measurement
NEIL COOK (SANTA CLARA, US) |
| 14:50 |
Personalizing cancer care through early assessment of response to treatment
ROBERT DANN (CHALFONT ST GILES, GB) |
| 15:15 |
Strategic vision of Applied Biosystems on advanced technology developments in life sciences
SIMONE GUENTHER (FOSTER CITY, US) |
| 15:40 |
A new statistical model and integrated advanced technologies appropriate for biomarker evaluation in clinical trials
VLADIMIR LAZAR (VILLEJUIF, FR) |
16:05 - 16:30: Coffee break and networking discussions
|
16:30 - 19:30: ADVANCED TECHNOLOGY DEVELOPMENTS (2)
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
ZOHAR YACHINI (HAIFA, IL), OLLI KALLIONIEMI (HELSINKI, FI) |
| 16:30 |
In silico molecular modelling for targeted therapy
MARCO PIEROTTI (MILAN, IT) |
| 16:55 |
New strategies for biomarker discovery by high-throughput proteomics and validation programs
JANNE LEHTIO (STOCKHOLM, SE) |
| 17:20 |
Intense parallel sequencing and high sensitivity identification of mutations, a clue for tailored treatment and for understanding response to treatment
JOAKIM LUNDEBERG (STOCKHOLM, SE) |
| 17:45 |
Molecular pathology: a new era in cancer diagnostics and tailored treatment
JI ZHANG (SHANGAI, CN) |
| 18:10 |
Epigenetic-based technologies to power personalized medicine
MANFRED SCHMITT (M?NCHEN, DE) |
| 18:40 |
Advanced technologies and innovative biological models to explore personalized medicine experimental approaches
ANTON BERNS (AMSTERDAM, NL) |
19:30 - 23:30: WELCOME RECEPTION
|
| |
| vendredi 10 juillet 2009 |
08:30 - 10:40: PERSONALIZED MEDICINE: PROOF-OF-CONCEPT AND MAJOR ACHIEVEMENTS IN LUNG CANCER AND PROSTATE CANCER
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
IGNACIO IVAN WISTUBA (HOUSTON, US), JI ZHANG (SHANGAI, CN) |
| 08:30 |
Opening keynote lecture: Molecular markers and cancer therapy
STANLEY HAMILTON (HOUSTON, US) |
| 09:00 |
Transcriptomic approaches to dissect lung cancer biology
ANIL POTTI (DURHAM, US) |
| 09:25 |
Expectations from personalized medicine in lung cancer: ready for customized trials ?
JEAN-CHARLES SORIA (VILLEJUIF, FR) |
| 09:50 |
Post treatment consequences of personalized therapy: Implications for future research
GEORGE SIMON (PHILADELPHIA, US) |
| 10:15 |
Circulating tumor cells in early clinical trials
JOHAN DE-BONNO (Senior Lecturer and Honorary Consultant Oncologist , SURREY, GB) |
10:40 - 11:00: Coffee break and networking discussions
|
11:00 - 12:40: PERSONALIZED MEDICINE: PROOF-OF-CONCEPT AND MAJOR ACHIEVEMENTS IN BREAST CANCER
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
RENE BERNARDS (AMSTERDAM, NL), STEPHEN FRIEND (PENNSYLVANIA, US) |
| 11:00 |
The war on breast cancer "Divide et impera"
LAJOS PUSZTAI (HOUSTON, US) |
| 11:25 |
Comparative genomic hybridization to tailor treatment of patients with breast cancer
FABRICE ANDRE (VILLEJUIF, FR) |
| 11:50 |
Bench to bed site: the current status of clinical practice and translational research in breast cancer in China
ZHIMIN SHAO (SHANGHAI, JP) |
| 12:15 |
Proteomics strategies in Breast Cancer Research
JULIO E CELIS (COPENHAGEN, DK) |
| 12:40 |
Development of Novel Molecular Imaging Agents for Selection and Monitoring of Personalized Tumor-Targeted Therapies
JURI GELOVANI (HOUSTON, US) |
13:05 - 14:30: Lunch and networking discussions
|
14:00 - 15:25: TRANS-NATIONAL NETWORKING CHALLENGES
|
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
JEAN-CHARLES SORIA (VILLEJUIF, FR), LAJOS PUSZTAI (HOUSTON, US) |
| 14:30 |
Cancer medicine networking in United States of America
RICHARD L. SCHILSKY (CHICAGO, US) |
| 14:55 |
Structuring efforts and strategic vision in Canada: challenges and needs
ALAN SPATZ (MONTREAL, CA) |
| 15:20 |
A European platform for translational cancer research
ULRIK RINGBORG (STOCKHOLM, SE) |
| 15:20 |
The European Research Platform Strategic Initiative. The Example of EU FP6 CHEMORES network(www.chemores.org)
JOHAN HANSON (STOCKHOLM, SE) |
15:45 - 16:15: Coffee break and networking discussions
|
16:00 - 19:00: UNMET NEEDS IN PERSONALIZED CANCER CARE. The challenges of international cooperation between clinicians, researchers, technology developers, biotechnology and pharmaceutical industry
OPEN INTERACTIVE FORUM:
With participation of :
- Thomas Tursz (Villejuif, France)
- Leroy Hood (Seattle, USA)
- Stanley Hamilton (Houston, USA)
- Ulrik Ringborg (Stockholm, Sweden)
- Ignacio I. Wistuba (Houston, USA)
- Stephen Friend (Seattle, USA)
- Olli Kallioniemi (Helsinski, Finland)
- Ding-Wei Ye (Shanghai, China)
- George Simon (Philadelphia, USA)
- Robert Sigal (Paris, France)
- Manfred Schmitt (Munich, Germany)
- René Bernards (Amsterdam, The Netherlands)
- Gilles Vassal (Villejuif, France)
- Zhang Ji (Shanghai, China)
- Vladimir Lazar (villejuif, France)
- Neil Cook (Santa Clara, USA)
- Rolf Lewensohn (Stockolm, Sweden)
- Joost van den Oord (Leuven, Belgium)
- Lajos Pusztai (Houston, Texas)
- Marco Pierotti (Milan, Italy)
- Anil Potti (Durham, USA)
- Jean-Charles Soria (Villejuif, France)
- Anton Berns (Amsterdam, The Netherlands)
- Alan Spatz (Montreal, Canada)
- Johan De-Bonno (London, United Kingdom)
- Joakim Lundeberg (Stockholm, Sweden)
- Fabrice Andre (Villejuif, France)
- Zohar Yakhini (Haifa, Israel)
- Simone Guenther (Foster City, USA)
- Johan Hanson (Stockholm, Sweden)
- Juri Gelovani (Houston, USA)
- Richard Booton (Manchester, United Kingdom) |
| Salles: |
AMPHITHEATRE BLEU |
| Modérateurs: |
JULIO E CELIS (COPENHAGEN, DK), RICHARD L. SCHILSKY (CHICAGO, US) |
19:00 - 19:30: CONCLUSIONS OF THE SYMPOSIUM
Thomas Tursz (Villejuif, France)-Stanley Hamilton (Houston, USA)-Ding-Wei Ye (Shanghai, China) |
| Salles: |
AMPHITHEATRE BLEU |
